期刊文献+

调节性B细胞在疾病免疫中的研究现状

Research advances of regulatory B cel s in immunologically mediated disease-review
下载PDF
导出
摘要 B细胞在体液免疫中发挥重要作用,并通过分泌各种抗体促进细胞免疫。调节性B细胞是近年来发现的存在于B细胞中的一种新的细胞亚群,其主要通过分泌IL-10、、IL-35等来抑制过度炎症反应,研究表明其在自身免疫疾病、移植免疫、肿瘤免疫、感染免疫中发挥着重要的作用。本文就调节性B细胞的来源、功能、作用机制及相关研究进展作一综述。 B cells play an important role in humoral immunity and promote cellular immunity by secreting various antibodies.In recent years,a new subset of cells found in B cells have been named regulatory B cells. Breg cells suppress excessive inflammatory responses mainly by secreting interleukin (IL)-10,IL-35 and so on. Breg cells play an important role in autoimmune diseases,transplantation immunity,tumor immunity and infection immunity.Therefore,this review summarizes the sources,functions,mechanisms and related research progress of regulatory B cells .
出处 《现代肿瘤医学》 CAS 2018年第7期1132-1135,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81600115)
关键词 Breg细胞 免疫疾病 研究进展 breg cells immunologically mediated disease research progress
  • 相关文献

参考文献1

二级参考文献22

  • 1陈育红,黄晓军,陈欢,许兰平,刘代红,江倩,张耀臣,韩伟,高志勇,王景枝,刘开彦,吴彤,陆道培.非血缘关系异基因造血干细胞移植66例分析[J].中华血液学杂志,2005,26(11):656-660. 被引量:19
  • 2CoghillJM, Sarantopoulos S, Moran TP, et al. Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood, 2011, 117: 3268-3276.
  • 3CarneiroJ, Leon K, Caramalho I, et al. When three is not a crowd: a Crossregulation model of the dynamics and repertoire selection of regulatory CD4 + T cells. Immunol Rev, 2007, 216: 48-68.
  • 4Javeed A, Zhao Y. The effects of immunosuppression on regula.tory CD4 ( + ) CD25 ( + ) T cells: impact on immunosuppression selection in transplantation. Mol Diagn Ther, 2008, 12: 17l- 181.
  • 5Jager A, Kucbroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. ScandJ Immunol, 2010, 72: 173-184.
  • 6Nagayama Y, Hase W, Motoyoshi Y, et al. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells. Oncol Rep, 2007, 17: 1269-1273.
  • 7Mandl SJ, Rountree RB, Dalpozzo K, et al. Immunotherapy with MVA-BN.-HER2 induces HER-2-specific Thl immunity and alters the intratumoral balance of effector and regulatory T cells. Cancer Immunollmmunother, 2012, 61:19-29.
  • 8Zhao XY, Lv M, Xu LL, et al. Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation. EurJ Immunol, 2013, 43: 838-850.
  • 9Zhao XY, Xu LL, Lu SY, et al. IL-17-producing T cells contribute to acute graft- versus- host disease in patients undergoing unmanipulated blood and marrow transplantation. EurJ Immunol, 20II, 41: 514-526.
  • 10Huang XJ, Liu DH, Liu KY, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T- cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant, 2006, 38: 291-297.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部